Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-(4-Methylpiperazin-1-yl)butan-1-amine → 5-{3-[4-(4-Methyl-piperazin-1-yl)-butyl]-ureido}-3-(2,3,6-trifluoro-4-methyl-benzyloxy)-isothiazole-4-carboxylic acid amide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-(4-Methylpiperazin-1-yl)butan-1-amine | HCID 6484192 | — |
| 반응물 | [4-Carbamoyl-3-(2,3,6-trifluoro-4-methyl-benzyloxy)-isothiazol-5-yl]-carbamic acid phenyl ester | HCID 54053016 | — |
| 생성물 | 5-{3-[4-(4-Methyl-piperazin-1-yl)-butyl]-ureido}-3-(2,3,6-trifluoro-4-methyl-benzyloxy)-isothiazole-4-carboxylic acid amide | HCID 10052189 | — |
반응 단계
The title compound was prepared from [4-carbamoyl-3-(2,3,6-trifluoro-4-methyl-benzyloxy)-isothiazol-5-yl]-carbamic acid phenyl ester and 4-(4-methyl-piperazin-1-yl)-butylamine by the procedure analogous to Example 1. MS (APCI, m/z): 515 [M+H]+.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US06235764B1 |
| 출처 데이터셋 | uspto-grants-2001_05 |
| ORD ID | ord-43a6ff8ee02b4b26b20c86e77a1754ec |
| 출처 메모 | uspto-grants-2001_05 |